FNY Investment Advisers’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 1141 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 979 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 923 |
|
|
2024
Q3 | – | Sell |
-10
| Closed | – | – | 817 |
|
|
2024
Q2 | $0 | Sell |
10
-2,882
| -100% | – | ﹤0.01% | 820 |
|
|
2024
Q1 | $274 | Buy |
+2,892
| New | +$274 | 0.17% | 105 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 775 |
|
|
2023
Q1 | – | Sell |
-100
| Closed | -$8K | – | 752 |
|
|
2022
Q4 | $8K | Buy |
+100
| New | +$8K | 0.01% | 312 |
|
|
2022
Q3 | – | Sell |
-2,000
| Closed | -$148K | – | 857 |
|
|
2022
Q2 | $148K | Buy |
2,000
+1,245
| +165% | +$92.1K | 0.11% | 125 |
|
|
2022
Q1 | $67K | Buy |
+755
| New | +$67K | 0.06% | 215 |
|
|
2020
Q2 | – | Sell |
-10,000
| Closed | -$774K | – | 579 |
|
|
2020
Q1 | $774K | Buy |
+10,000
| New | +$774K | 0.59% | 43 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 976 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 1200 |
|